| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 788,000 | 644,000 | 860,000 | 1,654,000 | | Cost of Revenue | 593,000 | 321,000 | 349,000 | 925,000 | | | Gross Profit | 195,000 | 323,000 | 511,000 | 729,000 | | | Operating Expenses | | Research Development | 316,000 | 312,000 | 332,000 | 298,000 | | Selling General and Administrative | 278,000 | 230,000 | 190,000 | 332,000 | | Non Recurring | 6,000 | 14,000 | 39,000 | 387,000 | | Others | 12,000 | 12,000 | 12,000 | 16,000 | | | | Total Operating Expenses | 612,000 | 568,000 | 573,000 | 1,033,000 | | | | Operating Income or Loss | (417,000) | (245,000) | (62,000) | (304,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,000) | (13,000) | 3,000 | (14,000) | | Earnings Before Interest And Taxes | (418,000) | (258,000) | (59,000) | (318,000) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (418,000) | (258,000) | (59,000) | (318,000) | | Income Tax Expense | (27,000) | (24,000) | (17,000) | 323,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (391,000) | (234,000) | (42,000) | (641,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (391,000) | (234,000) | (42,000) | (641,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($391,000) | ($234,000) | ($42,000) | ($641,000) |
|
0.68% Nasdaq 
Income Statement
